| TRADING CENTER |
| Good News for Dynavax - Analyst Blog - Zacks.com | |
| Dynavax's European Manufacturing Facility Approved for Commercial Production of ... - Market Wire |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| AMGN | Amgen Inc | 57.42 | 0.00 / 0.00% | 10.98 |
| GILD | Gilead Sciences Inc | 43.00 | 0.00 / 0.00% | 16.60 |
| CELG | Celgene Corporation | 56.38 | 0.00 / 0.00% | 67.93 |
| 2008 Revenue: | $37.1 M | Headquarters: Berkeley, CA |
| Employees: | 155 | CEO: Dr. Dino Dina, M.D. |
| Net Income: | $-20,829,000.0 | Industry: Biotechnology |
| Market Cap: | $59.9 M | Website: www.dynavax.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| DVAX | 1.45 | 0.00 / 0.00% | 1.45 | 0.00 | 0.00 | Profile Chart News |